Paper475375
Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
Billiau A and 4 others. Antimicrob Agents Chemother, 1979. Cited by 79 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans. Papers, record 475375. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/475375
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblasts | Major topic |
| Interferons | Major topic |
| Adolescent | |
| Adult | |
| Animals | |
| Antigens, Viral | |
| Child | |
| Child, Preschool | |
| Female | |
| Fever | |
| Humans | |
| Hypersensitivity, Delayed | |
| Injections, Intramuscular | |
| Injections, Intravenous | |
| Lymphopenia | |
| Male | |
| Middle Aged | |
| Pyrogens | |
| Rabbits | |
| Skin Tests |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 631,632 | Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. | Gut | 1978 | https://conductscience.org/library/papers/631632 | PubMed |
| 2 | 70,611 | Interferon skin reactivity and pyrexial reactions. | Lancet | 1977 | https://conductscience.org/library/papers/70611 | PubMed |
| 3 | 75,485 | Non-appearance of injected fibroblast interferon in circulation. | Lancet | 1978 | https://conductscience.org/library/papers/75485 | PubMed |
| 4 | 73,970 | Fibroblast interferon in HBsAg-positive chronic active hepatitis. | Lancet | 1977 | https://conductscience.org/library/papers/73970 | PubMed |
| 5 | 69,141 | Interferon-induced skin reactivity in man. | Lancet | 1977 | https://conductscience.org/library/papers/69141 | PubMed |
| 6 | 100,331 | Double-blind study of interferon administration in renal transplant recipients. | Eur J Clin Invest | 1978 | https://conductscience.org/library/papers/100331 | PubMed |
| 7 | 347,294 | Human leukocyte interferon for the treatment of herpes zoster in patients with cancer. | N Engl J Med | 1978 | https://conductscience.org/library/papers/347294 | PubMed |
| 8 | 475,374 | Human fibroblast interferon for clinical trials: production, partial purification, and characterization. | Antimicrob Agents Chemother | 1979 | https://conductscience.org/library/papers/475374 | PubMed |
| 9 | 893,388 | Purification of human fibroblast interferon by zinc chelate affinity chromatography. | J Biol Chem | 1977 | https://conductscience.org/library/papers/893388 | PubMed |
| 10 | 1,036,458 | Purification of interferon by adsorption chromatography on controlled pore glass. | J Gen Virol | 1976 | https://conductscience.org/library/papers/1036458 | PubMed |
| 11 | 965,787 | Morphology of delayed-type hypersensitivity reactions in man. | J Invest Dermatol | 1976 | https://conductscience.org/library/papers/965787 | PubMed |
| 12 | 4,947,653 | In vitro approaches to the mechanism of cell-mediated immune reactions. | Adv Immunol | 1971 | https://conductscience.org/library/papers/4947653 | PubMed |
| 13 | 4,601,181 | Administration of human leukocyte interferon in herpes zoster. I. Safety, circulating, antiviral activity, and host responses to infection. | J Infect Dis | 1974 | https://conductscience.org/library/papers/4601181 | PubMed |
| 14 | 4,355,215 | Clinical and laboratory investigations on man: systemic administration of potent interferon to man. | J Natl Cancer Inst | 1973 | https://conductscience.org/library/papers/4355215 | PubMed |
| 15 | 4,129,735 | Letter: Interferon in acute leukaemia in children. | Lancet | 1974 | https://conductscience.org/library/papers/4129735 | PubMed |
| 16 | 60,513 | Administration of human fibroblast interferon in chronic hepatitis-B infection. | Lancet | 1976 | https://conductscience.org/library/papers/60513 | PubMed |
| 17 | 4,719,686 | Biological effects of bacterial endotoxins in man. | J Infect Dis | 1973 | https://conductscience.org/library/papers/4719686 | PubMed |
| 18 | 779,593 | Biology of endotoxin. | Annu Rev Med | 1976 | https://conductscience.org/library/papers/779593 | PubMed |
| 19 | 950,957 | Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. | N Engl J Med | 1976 | https://conductscience.org/library/papers/950957 | PubMed |
| 20 | 932,502 | Comparison of rates of clearance of human fibroblast and leukocyte interferon from the circulatory system of rabbits. | J Infect Dis | 1976 | https://conductscience.org/library/papers/932502 | PubMed |
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 24,272,847 | Potentiation of enteral absorption of human interferon alpha and selective transfer into lymphatics in rats. | Pharm Res | 1985 | https://conductscience.org/library/papers/24272847 | PubMed |
| 8,984,676 | Mechanisms of action of interferon-beta in multiple sclerosis. | Springer Semin Immunopathol | 1996 | https://conductscience.org/library/papers/8984676 | PubMed |
| 7,354,125 | Pharmacokinetic properties of human fibroblast and leukocyte interferon in rabbits. | J Clin Microbiol | 1980 | https://conductscience.org/library/papers/7354125 | PubMed |
| 6,400,034 | The clinical application of fibroblast interferon--an overview. | Med Oncol Tumor Pharmacother | 1984 | https://conductscience.org/library/papers/6400034 | PubMed |
| 6,379,511 | Clinical effect of interferon in malignant brain tumours. | Neurosurg Rev | 1984 | https://conductscience.org/library/papers/6379511 | PubMed |
| 6,177,285 | Antiviral treatment of chronic hepatitis B virus infection: pharmacokinetics and side effects of interferon and adenine arabinoside alone and in combination. | Antimicrob Agents Chemother | 1982 | https://conductscience.org/library/papers/6177285 | PubMed |
| 6,173,188 | Interferons and interferon inducers: development of clinical usefulness and therapeutic promise. | Drugs | 1982 | https://conductscience.org/library/papers/6173188 | PubMed |
| 6,171,428 | Comparison of human fibroblast and leukocyte interferon in the treatment of severe laryngeal papillomatosis in children. | Eur J Pediatr | 1981 | https://conductscience.org/library/papers/6171428 | PubMed |
| 6,166,278 | Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice. | Arch Virol | 1981 | https://conductscience.org/library/papers/6166278 | PubMed |
| 6,165,341 | Differences between human alpha (leukocyte) and beta (fibroblast) interferons. | Arch Virol | 1981 | https://conductscience.org/library/papers/6165341 | PubMed |
| 6,163,417 | Interferon therapy: pharmacokinetic and pharmacological aspects. | Arch Virol | 1981 | https://conductscience.org/library/papers/6163417 | PubMed |
| 6,160,588 | Spontaneous production of human interferon. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6160588 | PubMed |
| 6,160,109 | Interferon in experimental viral infections in mice: tissue interferon levels resulting from the virus infection and from exogenous interferon therapy. | Infect Immun | 1980 | https://conductscience.org/library/papers/6160109 | PubMed |
| 6,159,043 | Interferon: therapeutic fact or fiction for the '80s? | Br Med J | 1980 | https://conductscience.org/library/papers/6159043 | PubMed |
| 6,088,712 | Chemosensitivity of malignant human brain tumors. Preliminary results. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6088712 | PubMed |
| 4,031,971 | Interferon-beta in patients with low-grade astrocytomas--a phase I study. | J Neurooncol | 1985 | https://conductscience.org/library/papers/4031971 | PubMed |
| 3,493,097 | Pyrogenic and haematological effects of the interferon-inducing 22K factor (interleukin 1 beta) from human leukocytes. | Clin Exp Immunol | 1986 | https://conductscience.org/library/papers/3493097 | PubMed |
| 2,425,443 | Interferons: current status and future directions of this prototypic biological. | Springer Semin Immunopathol | 1986 | https://conductscience.org/library/papers/2425443 | PubMed |
| 2,068,966 | Distribution of mouse interferon-beta in normal and brain tumour-bearing mice. | Acta Neurochir (Wien) | 1991 | https://conductscience.org/library/papers/2068966 | PubMed |
| 1,702,693 | Clinical pharmacokinetics of interferons. | Clin Pharmacokinet | 1990 | https://conductscience.org/library/papers/1702693 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/475375
GET https://conductscience.org/api/papers/v1/475375/references?page=2